Phase 1/2 trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms
| Image |  |
|---|---|
| Description | scholarly article by Anna B Halpern et al published 8 November 2018 in Haematologica |
| Author/s |
author: Megan Othus Elihu Estey |
| Publication date | November 8, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |